Entheon Biomedical Balance Sheet Health
Financial Health criteria checks 6/6
Entheon Biomedical has a total shareholder equity of CA$240.9K and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$291.9K and CA$51.0K respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
Interest coverage ratio | n/a |
Cash | CA$249.92k |
Equity | CA$240.89k |
Total liabilities | CA$51.01k |
Total assets | CA$291.90k |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ENBI's short term assets (CA$286.9K) exceed its short term liabilities (CA$51.0K).
Long Term Liabilities: ENBI has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ENBI is debt free.
Reducing Debt: ENBI had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ENBI has sufficient cash runway for 11 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: ENBI is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.